Dear Editor,
An increasing number of bacterial pathogens have been identified as mediators of apoptosis1 and apoptosis has also been described in monocytes/macrophages following in vivo and in vitro Mycobacterium tuberculosis (MTB) infection.2,3 This process is directly related to multiplicity of infection (MOI), occurring at the very early stages of in vitro infection, and does not require mycobacterial replication; moreover, it is characterized by a peculiar sequence of membrane modifications. In fact, membrane CD14 down-regulation, which normally mediates death signals in monocytes preceding the exposure of Annexin V binding sites,4 is a later occurring membrane event in the course of MTB-induced apoptosis.3 The peculiarity of the apoptotic pathway followed by monocytes/macrophages after infection with high amounts of MTB could have important implications as only certain of these pathways have been associated with mycobacterial killing.5 In this context, monocyte/macrophage apoptosis has been reported to be associated with mycobacterial survival rather than to its killing.3
On these grounds, it would be of interest to identify the mycobacterial molecule/s delivering death signals in monocytes. This issue has previously been studied in other bacterial infections and some apoptogenic bacterial molecules have already been described. For example, Shigella flexnery, an enteric pathogen responsible for bacillary dysentery, induces both in vitro and in vivo macrophage apoptosis6,7 by directly activating caspase-1 through its binding with the invasion plasmid antigen (IPA) B.8 Similarly, Salmonella invasion protein B (SipB) has also been reported to mediate macrophage apoptosis9 by binding to caspase-1. In these infections, caspase-1 mediated apoptosis allows efficient release of IL-1β, which triggers acute inflammation.6,7,8,9 Other bacterial molecules, like cell wall associated mycobacterial lipoproteins, have more recently been shown to induce cell activation and apoptosis in THP-1 monocyte cell lines and this effect is mediated by Toll-like receptor 2.10 Members of these surface associated mycobacterial lipoproteins are the 19-kDa and 38-kDa antigens, which are anchored in the cell wall by the lipid moiety and are expressed in the cell wall of MTB. While the biological function of the 19-kDa antigen is still unknown, the 38-kDa antigen has been reported to work as a phosphate binding protein.11
In this study, we have investigated the role of cell wall associated 19-kDa and 38-kDa lipoproteins in apoptosis occurring in monocytes/macrophages at the early stages of infection with high amounts of MTB H37Rv, by using anti-mycobacterial 19-kDa and anti-38-kDa monoclonal antibodies. Figure 1 shows increased levels of apoptosis in monocytes/macrophages, infected at a MOI of 20 with the virulent strain MTB H37Rv, already visible at 1 h after mycobacterial exposure in terms of both Annexin V (Figure 1A) and TUNEL (Figure 1B) positivity. In order to investigate the nature of the apoptogenic signal delivered by MTB H37Rv and the possible involvement of some mycobacterial wall lipoproteins in apoptosis induction, 40×106 CFU of MTB H37Rv were pre-incubated for 15 min at 37°C and 5% CO2 with 500 μg of anti-19-kDa (clone HYT 6, mouse IgG1), or anti-38-kDa (clone HBT 12, mouse IgG1) monoclonal antibodies suspended in 500 μl of PBS. As control, bacilli were pre-incubated with the same amount of anti-HLA (Human Leukocyte Antigen)-DP (clone B7/21, mouse IgG1) monoclonal antibody. After incubation, bacterial suspensions were used to infect monocytes/macrophages as previously described.3 Flow-cytometry analysis was performed on monocytes/macrophages infected or not with 20 bacilli per cell of MTB H37Rv pre-incubated with HYT 6, HBT 12 or B7/21 monoclonal antibodies. Figure 1C shows that the pre-opsonization of bacilli with anti-19 kDa monoclonal antibody resulted in a strong inhibition of MTB-induced apoptosis (Figure 1C, filled histogram, 21% of Annexin V positive cells). A slightly lower percentage of Annexin V positive cells was observed in time-matched MTB 37Rv uninfected monocytes/macrophages (Figure 1C,D,E empty histograms, 17% of Annexin V positive cells). The HYT 6-mediated effect resulted in an 80% inhibition when compared to the percentage of Annexin V positive monocytes/macrophages derived from MTB H37Rv infected and uninfected cultures (Figure 1A). Finally, the anti-19-kDa-mediated decrease of apoptosis appears to be specific. In fact, similar percentages of Annexin V positive cells were observed between monocytes/macrophages infected with untreated MTB H37Rv (Figure 1A) and monocytes/macrophages infected with MTB H37Rv either pre-opsonized with anti-mycobacterial 38 kDa (Figure 1D, filled histogram, 36% of Annexin V positive cells) or pre-incubated with anti-HLA-DP (Figure 1E, filled histogram, 34% of Annexin V positive cells) monoclonal antibodies.
The present study identifies mycobacterial 19-kDa lipoprotein as a key molecule mediating monocyte/macrophage apoptosis induced by high amounts of MTB H37Rv at the early stages of infection. However, the fact that the anti-19-kDa mediated inhibition was not complete (80%), suggests that other still unidentified mycobacterial molecules could be involved in this process. Our data are in accordance with previously reported results showing that bacterial lipoproteins can mediate (i) cell activation and pro-inflammatory signals;12 and (ii) apoptosis by binding with Toll-like receptor 2.10 In particular, IL-12 production, NF-κB and iNOS activation in response to mycobacterial 19-kDa has been reported in monocytes12 and a link between cell activation, as observed in terms of NF-κB activation, and apoptosis has been demonstrated following bacterial lipoprotein stimulation.10 In this context, cell activation and apoptosis can be induced by MTB infection depending upon the MOI used.3,13,14 In fact, previously reported results showed that low levels of MTB13 or BCG15 prevent monocyte apoptosis whereas high amounts of the virulent strain of MTB H37Rv can induce apoptosis.2,3 It is plausible, therefore, to hypothesize that the presence of a threshold signal, represented by the amount of mycobacteria and possibly by the amount of cell wall associated 19-kDa lipoprotein, determines whether the cell will live or die.
The study was supported by MURST-CNR Biotechnology Program L. 95/95 and by II Research Program on AIDS (50B.10) of the ISS.
References
Weinrauch Y et al.1999 Annu. Rev. Microbiol. 53: 155–187
Placido R et al.1997 J. Pathol. 181: 31–38
Santucci M et al.2000 J. Infect. Dis. 181: 1506–1509
Heidenreich S et al.1997 J. Immunol. 159: 3178–3188
Kornfeld H et al.1999 Cell Death Differ. 6: 71–78
Zychlinsky A et al.1992 Nature 358: 167–169
Zychlinsky A et al.1996 Infect. Immun. 64: 5357–5365
Hilbi H et al.1998 J. Biol. Chem. 273: 32895–32900
Hersh D et al.1999 Proc. Natl. Acad. Sci. USA 96: 2396–2401
Aliprantis AO et al.1999 Science 285: 736–739
Espitia C et al.1992 Infect. Immun. 60: 2998–3001
Brightbill HD et al.1999 Science 285: 732–736
Durrbaum-Landmann I et al.1996 Infect. Immun. 64: 5384–5389
Fraziano M et al.1999 AIDS Res. Human Retrovir. 15: 869–874
Kremer L et al.1997 Eur. J. Immunol. 27: 2450–2456
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ciaramella, A., Martino, A., Cicconi, R. et al. Mycobacterial 19-kDa lipoprotein mediates Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages at early stages of infection. Cell Death Differ 7, 1270–1272 (2000). https://doi.org/10.1038/sj.cdd.4400761
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400761
This article is cited by
-
Toll like-receptor agonist Pam3Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56
Medical Microbiology and Immunology (2020)
-
Innate immunity in tuberculosis: host defense vs pathogen evasion
Cellular & Molecular Immunology (2017)
-
Mycobacterium tuberculosis effectors interfering host apoptosis signaling
Apoptosis (2015)
-
Neutrophil apoptosis and the resolution of infection
Immunologic Research (2009)
-
Mycobacteria and innate cells: critical encounter for immunogenicity
Journal of Biosciences (2008)